Gastric cancer is one of the most common cancers in the world, despite declining incidence of the disease in the United States. Because of the rare occurrence of the disease in the United States, there is significant treatment variance in use of diagnostic modalities, neoadjuvant/adjuvant therapies, and surgical techniques. The survival of patients with gastric cancer in the United States is significantly lower than those of Asian countries where the diagnosis is made at an earlier stage and uniform high-quality treatment is delivered. This article reviews pearls and pitfalls of multidisciplinary management of the gastric adenocarcinoma for best outcomes.
Keywords: Diagnostic imaging; Endoscopy; Gastric cancer; Laparoscopy; Multimodality treatment; Neoadjuvant chemotherapy; Radiation therapy; Staging.
Copyright © 2020 Elsevier Inc. All rights reserved.